Incyte to Report Third Quarter 2014 Financial Results on October 30

WILMINGTON, Del.--()--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, October 30, 2014. The schedule for the press release and conference call is as follows:

                             

• Q3 2014 Press Release:

October 30, 2014 at 7:00 a.m. ET

• Q3 2014 Conference Call:

October 30, 2014 at 8:30 a.m. ET

• Domestic Dial-In Number:

877-407-8037

• International Dial-In Number:

201-689-8037

• Conference ID Number:

13592296
 

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13592296.

The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Contacts

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944

Contacts

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944